Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AERAS-404 and BCG Revaccination in Healthy Adolescents
NCT02075203Phase 2Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- Feb 2014
- Primary completion
- Aug 2017
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of H4:IC31 in Tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Started Feb 2014; status: completed.
02
Drugs
H4:IC31
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02075203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02075203.